Aequus Pharmaceuticals Stock Target Price
| AQSZF Stock | USD 0.01 0 18.18% |
Aequus Pharmaceuticals fundamentals help investors to digest information that contributes to Aequus Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Aequus OTC Stock. The fundamental analysis module provides a way to measure Aequus Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aequus Pharmaceuticals otc stock.
Aequus |
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Aequus Fundamentals
| Return On Equity | -2.92 | |||
| Return On Asset | -0.42 | |||
| Profit Margin | (1.36) % | |||
| Operating Margin | (1.31) % | |||
| Current Valuation | 3.03 M | |||
| Shares Outstanding | 132.63 M | |||
| Shares Owned By Insiders | 14.96 % | |||
| Price To Earning | (1.79) X | |||
| Price To Book | 32.78 X | |||
| Price To Sales | 1.44 X | |||
| Revenue | 2.71 M | |||
| Gross Profit | 2.69 M | |||
| EBITDA | (1.23 M) | |||
| Net Income | (1.81 M) | |||
| Cash And Equivalents | 1.39 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 26.09 K | |||
| Debt To Equity | 1.39 % | |||
| Current Ratio | 0.78 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (1.17 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 14 | |||
| Beta | 0.44 | |||
| Market Capitalization | 4.12 M | |||
| Total Asset | 4.35 M | |||
| Retained Earnings | (5.72 M) | |||
| Working Capital | (246 K) | |||
| Current Asset | 458 K | |||
| Current Liabilities | 704 K | |||
| Z Score | 93.4 | |||
| Net Asset | 4.35 M |
About Aequus Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aequus Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aequus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aequus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Aequus OTC Stock
Aequus Pharmaceuticals financial ratios help investors to determine whether Aequus OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aequus with respect to the benefits of owning Aequus Pharmaceuticals security.